HealthcareServices

Addictions Therapeutics Market Anticipated to Record Steady Gains, Advancing to $10.24 Billion by 2030

February 19, 2026February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the addictions therapeutics market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Addictions Therapeutics Market reach by 2030 starting from 2026 levels?

The addictions therapeutics market size has demonstrated robust expansion over recent years. This market is projected to expand from $7.46 billion in 2025 to $7.93 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.2%. Historically, this expansion has been driven by factors such as the increasing prevalence of substance use disorders, greater awareness regarding addiction treatment, a rise in specialized treatment centers, the uptake of buprenorphine and naltrexone therapies, and the broadening of hospital and clinical networks.

The market size for addictions therapeutics is anticipated to experience robust expansion in the coming years, projected to reach $10.24 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. Factors contributing to this growth during the forecast period include the creation of new addiction treatments, increased funding from both government and private sources for substance use disorder (SUDs) programs, the expansion of telehealth and digital platforms for treatment, a growing integration of mental health with addiction therapies, and broader public-private collaborations in addiction care. Key trends expected throughout the forecast period encompass an escalating demand for medication-assisted treatment (MAT), the proliferation of both inpatient and outpatient addiction treatment facilities, a greater uptake of telehealth and remote counseling solutions, an intensified focus on therapies for nicotine and opioid addiction, and more robust awareness campaigns concerning substance use disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12129&type=smp

Which Drivers Are Influencing Long-Term Growth In The Addictions Therapeutics Market?

The addiction therapeutics market is projected to grow due to the increasing consumption of alcohol. Alcohol consumption refers to the act of drinking beverages that contain ethyl alcohol. Addiction therapeutics are employed to manage alcohol addiction, helping individuals decrease their alcohol intake by counteracting its depressive effects and restoring the balance between the excitatory neurotransmitter glutamate and the inhibitory neurotransmitter gamma-aminobutyric acid. This process lessens alcohol cravings, alleviates symptoms, and suppresses issues such as insomnia, anxiety, and restlessness that are associated with alcohol withdrawal. For instance, in December 2024, Kirin Holdings Co. Ltd., a Japan-based company involved in alcoholic, non-alcoholic beverages, and pharmaceuticals, reported that global beer consumption in 2023 saw a minor increase of approximately 200,000 kl compared to 2022, reaching about 187.9 million kl, which is equivalent to roughly 296.9 billion 633 ml bottles, indicating a slight year-over-year growth of 0.1%. Therefore, the rising consumption of alcohol is a key driver for the addiction therapeutics market.

How Is The Addictions Therapeutics Market Divided Into Segments?

The addictions therapeutics market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs

2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment

3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center

4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel

Subsegments:

1) By Buprenorphine: Subutex, Suboxone

2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)

3) By Bupropion: Wellbutrin, Zyban

4) By Disulfiram: Antabuse, Generic Disulfiram

5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges

6) By Varenicline: Chantix (Champix), Generic Varenicline

7) By Other Drugs: Acamprosate, Topiramate, Gabapentin

Which Trends Are Shaping Activity Within The Addictions Therapeutics Market?

Leading firms operating in the addiction therapeutics market are creating novel solutions, including medications for cocaine use disorders (CUD), with the goal of expanding their client base, boosting sales, and increasing profits. These drugs for cocaine use disorders (CUD) are pharmaceuticals intended to assist people dealing with cocaine addiction or dependency. As an example, in January 2023, Tempero Bio, a US-based biopharmaceutical firm, reported that the U.S. Food and Drug Administration (FDA) had approved its product, TMP-301. TMP-301, the company’s experimental compound, is notable for its function as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). Designed specifically for the significant treatment of cocaine use disorders (CUD), TMP-301 is distinguished by its strength, specificity, and oral administration, all designed to effectively reduce the excessive glutamate signaling linked to CUD.

Which Major Firms Are Strengthening Their Position In The Addictions Therapeutics Market?

Major companies operating in the addictions therapeutics market are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Addictions Therapeutics Market?

North America was the largest region in the addictions therapeutics market in 2025. The regions covered in the addictions therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Addictions Therapeutics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12129&type=smp

Browse Through More Reports Similar to the Global Addictions Therapeutics Market 2026, By The Business Research Company

Substance Abuse And Addiction Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/substance-abuse-and-addiction-treatment-global-market-report

Substance Abuse And Addiction Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/substance-abuse-and-addiction-treatment-global-market-report

Nicotine Addiction Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/nicotine-addiction-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795